NUCRYST Pharmaceuticals Corp. (NASDAQ: NCST)

NUCRYST Pharmaceuticals Corp. (NASDAQ: NCST) is focused on developing, manufacturing, and commercializing medical products designed to fight infection and inflammation based on the company’s patented atomically disordered nanocrystalline silver technology. NUCRYST has found success developing and manufacturing Acticoat™ dressings with SILCRYST™ nanocrystals for Smith & Nephew plc. These products are currently in use by hospitals, clinics, burn centers, doctor’s offices, home healthcare agencies and nursing homes around the globe. For further information, visit the Company’s web site at www.nucryst.com.